Make your money go further for just 25p per day

AIM IHT

Settlement disappoints | FDA approvals encourage

06/06/2023 · Advanced Medical Solutions (AMS)  · Anexo Group PLC (ANX)  · Diaceutics PLC (DXRX)  · Tristel (TSTL)  · Watkin Jones PLC (WJG) 

AIM AIM Inheritance Tax potential UK

Tristel spray

Updates covered here include news of a cash settlement for an unloved legal services business, a significant forward sale for an equally unloved developer and approvals for two more highly rated companies supporting the health sector. Read on here for this and other news.


Diaceutics: significant contract award

Diaceutics (AIM: DXRX), a technology and solutions provider to the pharmaceutical industry, announced a three-year enterprise contract with a US-based top 10 global pharmaceutical company.

The contract will initially deliver US$10.1m of revenue over a three-year period, however, there are additional options which, if exercised, would significantly increase the scope and value over this period. Revenue is expected to be recognised on a monthly basis, spread broadly evenly…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Advanced Medical Solutions

Episode 9 of the Investor’s Champion Podcast

16/03/2024 · Podcasts

This episode discusses Bitcoin's surging price, the UK competition authority's probe into the veterinary sector, Trainline's growth and…


AIM’s world leaders are poised

13/03/2024 · Company Insights

We pick through the latest results from two of AIM’s world leaders. The shares of both…


More on Anexo Group PLC

AIM new arrivals July | Improving cash flow

30/08/2023 · Company Insights

July proved to be another quiet month for IPOs on AIM with only one new arrival…


Settlement disappoints | FDA approvals encourage

06/06/2023 · Company Insights

Updates covered here include news of a cash settlement for an unloved legal services business, a…


More on Diaceutics PLC

Settlement disappoints | FDA approvals encourage

06/06/2023 · Company Insights

Updates covered here include news of a cash settlement for an unloved legal services business, a…


What is AIM’s exposure to Silicon Valley Bank?

14/03/2023 · Company Insights

One of AIM’s largest companies announced cracking full year results with a big increase in its…


More on Tristel

Cracking results | Questionable shareholder value

26/02/2024 · Company Insights

News covered here include cracking results from a highly-rated provider of infection prevention products, which has…


Paddling furiously, to go backwards!

23/01/2024 · Company Insights

A popular AIM company covered here is struggling to make a return on substantial revenue –…


More on Watkin Jones PLC

Paddling furiously, to go backwards!

23/01/2024 · Company Insights

A popular AIM company covered here is struggling to make a return on substantial revenue –…


Construction commitment | Excellent results | Profit warning

11/10/2023 · Company Insights

News covered here include excellent results from a highly-regarded research and data analytics group, which for…


More Company Insights

Bonkers Bargain: poised for recovery

16/04/2024 · Gattaca PLC

Takeover mania | Encouraging flows

Sign-up to our free email updates

SIGN UP